| LINE ITEM (USD / %) | FY 2025
FILED 2026-03-31 | FY 2024
FILED 2025-03-31 | FY 2023
FILED 2024-03-31 |
|---|---|---|---|
| Revenue (Total Sales) | $5.4M | $4.2M | $5.2M |
| YoY Revenue Growth % | +28.5% | -18.9% | — |
| Gross Profit | $757.6K | $634.3K | — |
| Gross Margin % | 14.1% | 15.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$1.5M | -$1.8M | -$1.1M |
| Operating Margin % | -28.5% | -43.5% | -21.9% |
| Net Income (GAAP) | -$4.5M | -$5.1M | -$3.1M |
| EBITDA (Normalized) | -$1.4M | -$1.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$603.6K | $816.0K | -$411.5K |
| Capital Expenditures (CapEx) | $180.9K | $197.6K | — |
| Free Cash Flow (FCF) | -$784.5K | $618.4K | -$411.5K |
| FCF Margin % | -14.6% | 14.8% | -8.0% |
| Return on Invested Capital (ROIC %) | -5.6% | -6.2% | — |
| Cash & Short-Term Equivalents | $238.5K | $480.1K | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $21.6M | $23.8M | — |